Apogem Capital’s Shattuck Labs STTK Stock Holding History
Bought
Maintained
Sold
Other funds holding STTK
RG
PM
CEI
LCM
IMOV
Apogem Capital's STTK Position: Q4 2022 in Review
Apogem Capital sold out of Shattuck Labs (STTK) in Q4 2022, closing a stake of 78,757 shares — an estimated $213K sold.
Apogem Capital first reported a position in STTK in Q3 2021 and held it in 5 quarters. The position peaked at $309K in Q2 2022. 48 funds tracked by Wall St. Rank hold STTK as of Q4 2022.
- Apogem Capital reported no remaining Shattuck Labs position as of Q4 2022 after selling out during the quarter.
- Apogem Capital sold 78,757 Shattuck Labs shares in Q4 2022, an estimated $213K.
- Apogem Capital first reported a position in Shattuck Labs in Q3 2021 and held it in 5 quarters.
- Apogem Capital's Shattuck Labs position peaked at $309K in Q2 2022.
- 48 funds tracked by Wall St. Rank held Shattuck Labs as of Q4 2022.
Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.